Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Microbial Issues

Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage

Bone Marrow Transplantation volume 48, pages 74–79 (2013)Cite this article

Subjects

Abstract

To clarify the clinical features and outcome of Stenotrophomonas maltophilia infection among hematopoietic SCT (HCT) recipients, we retrospectively reviewed the records of 1085 consecutive HCT recipients and identified 42 episodes in 31 HCT recipients with S. maltophilia infection. We compared these recipients with 30 non-HCT patients with S. maltophilia infection. The mortality rate in HCT recipients was significantly higher than that in non-HCT patients (relative risk 5.7, P=0.04), and we identified seven patients with pulmonary hemorrhage due to S. maltophilia, exclusively in the HCT cohort. Six of these latter seven patients died within 1 day from the onset of hemorrhage and the isolate was identified after death in most cases; one patient, who received empiric therapy for S. maltophilia and granulocyte transfusion, survived for more than 2 weeks. The patients with pulmonary hemorrhage had a more severe and longer duration of neutropenia, persistent fever despite of the use of broad-spectrum antibiotics, complication by pneumonia and higher C-reactive protein levels than those without pulmonary hemorrhage. In conclusion, S. maltophilia was associated with fulminant and fatal pulmonary hemorrhage in HCT recipients. Empiric therapy with antibiotics before the onset of pulmonary hemorrhage may be effective in HCT recipients who carry the conditions identified.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Looney WJ, Narita M, Muhlemann K . Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 2009; 9: 312–323.

    Article  CAS  Google Scholar 

  2. Hoefel D, Monis PT, Grooby WL, Andrews S, Saint CP . Profiling bacterial survival through a water treatment process and subsequent distribution system. J Appl Microbiol 2005; 99: 175–186.

    Article  CAS  Google Scholar 

  3. Spencer RC . The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30 (Suppl): 453–464.

    Article  Google Scholar 

  4. Cervia JS, Ortolano GA, Canonica FP . Hospital tap water as a source of Stenotrophomonas maltophilia infection. Clin Infect Dis 2008; 46: 1485–1487.

    Article  Google Scholar 

  5. Khardori N, Reuben A, Rosenbaum B, Rolston K, Bodey GP . In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob Agents Chemother 1990; 34: 1609–1610.

    Article  CAS  Google Scholar 

  6. Nicodemo AC, Paez JI . Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 2007; 26: 229–237.

    Article  CAS  Google Scholar 

  7. Safdar A, Rolston KV . Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 2007; 45: 1602–1609.

    Article  Google Scholar 

  8. Boktour M, Hanna H, Ansari S, Bahna B, Hachem R, Tarrand J et alCentral venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 2006; 106: 1967–1973.

    Article  Google Scholar 

  9. Metan G, Hayran M, Hascelik G, Uzun O . Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis 2006; 38: 527–531.

    Article  Google Scholar 

  10. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC et alVentilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157: 531–539.

    Article  CAS  Google Scholar 

  11. Martino R, Martinez C, Pericas R, Salazar R, Solá C, Brunet S et alBacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors. Eur J Clin Microbiol Infect Dis 1996; 15: 610–615.

    Article  CAS  Google Scholar 

  12. Labarca JA, Leber AL, Kern VL, Territo MC, Brankovic LE, Bruckner DA et alOutbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis 2000; 30: 195–197.

    Article  CAS  Google Scholar 

  13. Araoka H, Baba M, Yoneyama A . Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis 2010; 29: 605–608.

    Article  CAS  Google Scholar 

  14. Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S et alBacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000; 31: 705–711.

    Article  CAS  Google Scholar 

  15. Muder RR, Harris AP, Muller S, Edmond M, Chow JW, Papadakis K et alBacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis 1996; 22: 508–512.

    Article  CAS  Google Scholar 

  16. Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF . Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis 2008; 27: 901–906.

    Article  Google Scholar 

  17. Paez JI, Costa SF . Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect 2008; 70: 101–108.

    Article  Google Scholar 

  18. Chaplow R, Palmer B, Heyderman R, Moppett J, Marks DI . Stenotrophomonas maltophilia bacteraemia in 40 haematology patients: risk factors, therapy and outcome. Bone Marrow Transplant 2010; 45: 1109–1110.

    Article  CAS  Google Scholar 

  19. Yeshurun M, Gafter-Gvili A, Thaler M, Keller N, Nagler A, Shimoni A . Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience. Infection 2010; 38: 211–215.

    Article  CAS  Google Scholar 

  20. Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW . Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect 2002; 45: 47–53.

    Article  CAS  Google Scholar 

  21. Korvick JA, Bryan CS, Farber B, Beam TR, Schenfeld L, Muder RR et alProspective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 1992; 36: 2639–2644.

    Article  CAS  Google Scholar 

  22. Chow JW, Yu VL . Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999; 11: 7–12.

    Article  CAS  Google Scholar 

  23. Portugal RD, Garnica M, Nucci M . Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve. J Clin Oncol 2009; 27: 3849–3854.

    Article  Google Scholar 

  24. Majhail NS, Parks K, Defor TE, Weisdorf DJ . Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Biol Blood Marrow Transplant 2006; 12: 1038–1046.

    Article  Google Scholar 

  25. Wanko SO, Broadwater G, Folz RJ, Chao NJ . Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid. Biol Blood Marrow Transplant 2006; 12: 949–953.

    Article  CAS  Google Scholar 

  26. Gupta S, Jain A, Warneke CL, Gupta A, Shannon VR, Morice RC et alOutcome of alveolar hemorrhage in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007; 40: 71–78.

    Article  CAS  Google Scholar 

  27. Elsner HA, Duhrsen U, Hollwitz B, Kaulfers PM, Hossfeld DK . Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia. Ann Hematol 1997; 74: 155–161.

    Article  CAS  Google Scholar 

  28. Rousseau A, Morcos M, Amrouche L, Foïs E, Casetta A, Rio B et alLethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient. Leuk Lymphoma 2004; 45: 1293–1296.

    Article  Google Scholar 

  29. Ortin X, Jaen-Martinez J, Rodriguez-Luaces M, Alvaro T, Font L . Fatal pulmonary hemorrhage in a patient with myelodysplastic syndrome and fulminant pneumonia caused by Stenotrophomonas maltophilia. Infection 2007; 35: 201–202.

    Article  CAS  Google Scholar 

  30. Takahashi N, Yoshioka T, Kameoka Y, Tagawa H, Fujishima N, Saitoh H et alFatal hemorrhagic pneumonia caused by Stenotrophomanas maltophilia in a patient with non-Hodgkin lymphoma. J Infect Chemother 2011; 17: 858–862.

    Article  Google Scholar 

  31. O'Brien M, Davis GH . Enzymatic profile of Pseudomonas maltophilia. J Clin Microbiol 1982; 16: 417–421.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Windhorst S, Frank E, Georgieva DN, Genov N, Buck F, Borowski P et alThe major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia: characterization of the protein and molecular cloning of the gene. J Biol Chem 2002; 277: 11042–11049.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan

    K Tada, S Kurosawa, N Hiramoto, K Okinaka, N Ueno, Y Asakura, S-W Kim, T Yamashita, S-I Mori, Y Heike, K Tobinai & T Fukuda

  2. Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan

    A M Maeshima & R Tanosaki

Authors
  1. K Tada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Kurosawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Hiramoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Okinaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Ueno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y Asakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S-W Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S-I Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Y Heike
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A M Maeshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R Tanosaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. K Tobinai
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. T Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T Fukuda.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tada, K., Kurosawa, S., Hiramoto, N. et al. Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage. Bone Marrow Transplant 48, 74–79 (2013). https://doi.org/10.1038/bmt.2012.87

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.87

Keywords

This article is cited by

Search

Advanced search

Quick links